UBS Group’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4M Buy
97,240
+16,121
+20% +$2.22M ﹤0.01% 2196
2025
Q1
$14.6M Sell
81,119
-19,012
-19% -$3.43M ﹤0.01% 2040
2024
Q4
$15.7M Buy
100,131
+63,802
+176% +$10M ﹤0.01% 1971
2024
Q3
$6.61M Buy
36,329
+7,773
+27% +$1.41M ﹤0.01% 2022
2024
Q2
$5.24M Sell
28,556
-22,472
-44% -$4.13M ﹤0.01% 2107
2024
Q1
$9.08M Buy
51,028
+20,268
+66% +$3.61M ﹤0.01% 1676
2023
Q4
$3.82M Buy
+30,760
New +$3.82M ﹤0.01% 2242
2023
Q3
Sell
-11,217
Closed -$1.32M 8507
2023
Q2
$1.32M Sell
11,217
-16,911
-60% -$1.99M ﹤0.01% 3068
2023
Q1
$2.25M Sell
28,128
-14,495
-34% -$1.16M ﹤0.01% 2481
2022
Q4
$3.38M Buy
42,623
+42,459
+25,890% +$3.36M ﹤0.01% 2130
2022
Q3
$11K Sell
164
-15,670
-99% -$1.05M ﹤0.01% 7202
2022
Q2
$1.04M Sell
15,834
-42,236
-73% -$2.77M ﹤0.01% 2866
2022
Q1
$3.86M Buy
58,070
+56,237
+3,068% +$3.74M ﹤0.01% 2129
2021
Q4
$128K Sell
1,833
-21,490
-92% -$1.5M ﹤0.01% 5016
2021
Q3
$1.22M Buy
23,323
+21,315
+1,062% +$1.11M ﹤0.01% 3104
2021
Q2
$137K Sell
2,008
-35,379
-95% -$2.41M ﹤0.01% 4601
2021
Q1
$2.88M Buy
37,387
+23,258
+165% +$1.79M ﹤0.01% 2442
2020
Q4
$848K Buy
14,129
+2,192
+18% +$132K ﹤0.01% 3270
2020
Q3
$514K Buy
11,937
+11,666
+4,305% +$502K ﹤0.01% 3409
2020
Q2
$11K Sell
271
-16,539
-98% -$671K ﹤0.01% 6093
2020
Q1
$727K Buy
16,810
+5,636
+50% +$244K ﹤0.01% 2914
2019
Q4
$619K Sell
11,174
-21,394
-66% -$1.19M ﹤0.01% 3725
2019
Q3
$1.13M Buy
32,568
+31,843
+4,392% +$1.11M ﹤0.01% 3107
2019
Q2
$29K Buy
+725
New +$29K ﹤0.01% 5488
2019
Q1
Sell
-675
Closed -$14K 6983
2018
Q4
$14K Buy
+675
New +$14K ﹤0.01% 6118
2017
Q4
Sell
-2,562
Closed -$26K 6913
2017
Q3
$26K Buy
+2,562
New +$26K ﹤0.01% 5371